Relay Therapeutics
Quiet monthRelay Therapeutics is strengthening its clinical and commercial infrastructure, bringing in four hires over 90 days — all in health professional roles — with no departures observed. The company added director-level oncology expertise from AstraZeneca and Agios Pharmaceuticals, including a Senior Director Physician Scientist for Oncology R&D and a Director of Regional Medical Science Liaison for APAC. The pattern signals preparation for late-stage clinical execution and global market expansion, drawing talent from established oncology players Daiichi Sankyo and Menarini Stemline as well.
- flat
- Net headcount · 90d
- +0
- New hires · 90d
- 0
- none
- Departures · 90d
- 0
- quiet
- Leadership moves · 90d
- 0
Get the weekly briefing on Relay Therapeutics
Hires, exits and promotions across Relay Therapeutics and its rivals — every Monday. Drop your email, no account needed.
One short email a week. Unsubscribe anytime.
Hiring pace
New hires per month, last 12 months. 13 total hires.
Oct 2025
Nov 2025
Dec 2025
Jan 2026
Feb 2026
Mar 2026
Apr 2026
May 2026
Jun 2026
Jul 2026
Aug 2026
Sep 2026
Notable moves
Hires, exits and promotions over the last 90 days — by role and function.
No major moves detected in the last 90 days — sometimes the signal is that there's no signal.
Where they're growing
Net change by function, last 90 days.
No notable function shifts in this window.
Flight risk watch
No elevated cluster of senior exit signals right now. Inkling flags one when it appears — track this market.
This is one desk. Build one for your market.
Inkling watches the people at every company you compete with and briefs you weekly
— the hire before the launch, the exit before it shows on their profile.
Aggregate signals refresh weekly. Moves are drawn from public profiles and reported by role — we never name individuals on this page.